Acceptance and Commitment Therapy for Religious OCD
- NCT ID
- NCT06647589
- Registry status
- Recruiting
- Study type
- Interventional
- Phase
- Not applicable
- Sponsor
- University of Alabama at Birmingham
- Conditions
- Obsessive-Compulsive Disorder (OCD)
Overview
ClinicalTrials.gov lists this study as Recruiting.
Official title: Efficacy of Acceptance and Commitment Therapy on Religiously Oriented Obsessive-Compulsive Disorder
Enrollment: 10 participants (Estimated).
What is being studied
- Behavioral: Acceptance and Commitment Therapy
- Intervention: Acceptance and Commitment Therapy
- Intervention: Behavior Therapy
- Intervention: Behavioral Disciplines and Activities
- Intervention: Cognitive Behavioral Therapy
- Intervention: Psychotherapy
Who may be eligible
- Ages
- 18 Years to no maximum
- Sex
- All
- Healthy volunteers accepted
- No
ClinicalTrials.gov lists the following eligibility criteria.
Study locations
1 study location is listed.
Recruiting site status is explicitly provided for 1 location; 1 is listed as Recruiting.
Countries: United States
- Alabama, United States: 1
Sample of listed locations
- University of Alabama at Birmingham — Birmingham, Alabama, 35233, United States — Recruiting
Study details
- Start date
- July 30, 2025
- Primary completion date
- March 1, 2027
- Completion date
- March 1, 2027
- First posted
- October 18, 2024
Source and update information
- Source
- ClinicalTrials.gov
- NCT ID
- NCT06647589
- Registry last updated
- September 28, 2026
- QualifiedStudies registry data refreshed
- October 5, 2026
- QualifiedStudies record fetched
- October 5, 2026
View NCT06647589 on ClinicalTrials.gov
Trial information can change. Confirm current study details with the study team or the registry.
About joining clinical research
Find clinical trials you may match with
QualifiedStudies can help you search for research opportunities related to your health. Availability of this specific study through QualifiedStudies has not been established.
Find clinical trials you may match with | Anxiety studies | Clinical trial FAQ